- Home
- VNET vs CGON Comparison
VNET vs CGON Comparison
Compare VNET & CGON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNET
- CGON
- Stock Information
- Founded
- VNET 1999
- CGON 2010
- Country
- VNET China
- CGON United States
- Employees
- VNET N/A
- CGON N/A
- Industry
- VNET Computer Software: Programming Data Processing
- CGON
- Sector
- VNET Technology
- CGON
- Exchange
- VNET Nasdaq
- CGON NYSE
- Market Cap
- VNET 1.7B
- CGON 2.0B
- IPO Year
- VNET 2011
- CGON 2024
- Fundamental
- Price
- VNET $7.95
- CGON $26.51
- Analyst Decision
- VNET Strong Buy
- CGON Strong Buy
- Analyst Count
- VNET 3
- CGON 10
- Target Price
- VNET $10.73
- CGON $64.44
- AVG Volume (30 Days)
- VNET 6.9M
- CGON 809.8K
- Earning Date
- VNET 08-26-2025
- CGON 08-07-2025
- Dividend Yield
- VNET N/A
- CGON N/A
- EPS Growth
- VNET N/A
- CGON N/A
- EPS
- VNET N/A
- CGON N/A
- Revenue
- VNET $1,186,131,469.00
- CGON $662,000.00
- Revenue This Year
- VNET $15.44
- CGON N/A
- Revenue Next Year
- VNET $19.86
- CGON $25,206.93
- P/E Ratio
- VNET $132.01
- CGON N/A
- Revenue Growth
- VNET 14.68
- CGON 224.51
- 52 Week Low
- VNET $1.71
- CGON $14.80
- 52 Week High
- VNET $16.13
- CGON $40.47
- Technical
- Relative Strength Index (RSI)
- VNET 65.91
- CGON 54.72
- Support Level
- VNET $6.82
- CGON $25.80
- Resistance Level
- VNET $7.76
- CGON $27.56
- Average True Range (ATR)
- VNET 0.51
- CGON 1.00
- MACD
- VNET 0.14
- CGON 0.04
- Stochastic Oscillator
- VNET 98.14
- CGON 67.97
About VNET VNET Group Inc.
VNET started as AsiaCloud in 1999 and moved to the data center business with its first self-developed data center opening in 2010. The firm listed (as 21Vianet) on the Nasdaq in April 2011, subsequently changing its name to VNET Group in 2021. It originally focused on providing data center services such as colocation and cloud services to retail clients in China, but added hyperscale customers in 2019 and now counts large Chinese hyperscalers such as Alibaba Cloud, Tencent Cloud, and Huawei Cloud as customers. At the end of June 2024, it had 48,516 self-built retail cabinets with the majority in Beijing, Shanghai, and the Greater Bay area. It also had 358 MW of wholesale capacity in service with a further 297 MW under construction and a further 489 MW held for future development.
About CGON CG ONCOLOGY INC
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.